日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Synthesis and Biological Evaluation of Imidazopyridine-Isatin Hybrids as Inhibitors of Leishmania major Growth

咪唑并吡啶-靛红杂合物作为利什曼原虫生长抑制剂的合成及生物学评价

El Hassab, Mahmoud A; Eldehna, Wagdy M; Elsayed, Zainab M; Elbadawi, Mostafa M; Negmeldin, Ahmed T; Balaha, Marwa; Nasralla, Sherry N; Monir, Rehan; Ibrahim, Tamer M; Abe, Manabu; Tawfik, Haytham O; Bekhit, Adnan A; Hemeda, Loah R

Discovery of potent bisindole-based pyrazolopyridine derivatives as topoisomerase inhibitors: DNA damage induction and synergistic antileukemic activity

发现强效的基于双吲哚的吡唑并吡啶衍生物作为拓扑异构酶抑制剂:DNA损伤诱导和协同抗白血病活性

Eldehna, Wagdy M; Tawfik, Haytham O; Veselá, Denisa; Peřina, Miroslav; Negmeldin, Ahmed T; Elsayed, Zainab M; Majrashi, Taghreed A; Vojáčková, Veronika; Elbadawi, Mostafa M; Shaldam, Moataz A; Kryštof, Vladimír; Abdel-Aziz, Hatem A

Pyrazole-triazole hybrids as kinase-triad inhibitors: a triple-target strategy for synergistic anticancer therapy

吡唑-三唑杂合物作为激酶三联体抑制剂:一种用于协同抗癌治疗的三靶点策略

Elkotamy, Mahmoud S; Elgohary, Mohamed K; Fakhry, Mariam M; Albakri, Mohamed E; Naglah, Abdelrahman A; Almehizia, Abdulrahman A; Naglah, Ahmed M; Fares, Mohamed; Tawfik, Haytham O; Eldehna, Wagdy M; Abdel-Aziz, Hatem A

Synthesis of new trans-ferulic acid derivatives as potential anticancer agents and VEGFR-2 inhibitors

合成新型反式阿魏酸衍生物作为潜在的抗癌剂和VEGFR-2抑制剂

Mohie, Asmaa N; Doheim, Mahmoud A; El Masry, Ragab A; Gomaa, Ayman M; Salem, Rofaida; Tawfik, Haytham O; Eldehna, Wagdy M

Development of New Pyrazolo [3,4-b]Pyridine Derivatives as Potent Anti-Leukemic Agents and Topoisomerase IIα Inhibitors with Broad-Spectrum Cytotoxicity

开发新型吡唑并[3,4-b]吡啶衍生物作为强效抗白血病药物和具有广谱细胞毒性的拓扑异构酶IIα抑制剂

Eldehna, Wagdy M; Tawfik, Haytham O; Veselá, Denisa; Vojáčková, Veronika; Negmeldin, Ahmed T; Elsayed, Zainab M; Majrashi, Taghreed A; Krňávková, Petra; Elbadawi, Mostafa M; Shaldam, Moataz A; Al-Ansary, Ghada H; Kryštof, Vladimír; Abdel-Aziz, Hatem A

Discovery of Novel Piperidinyl-Based Benzoxazole Derivatives as Anticancer Agents Targeting VEGFR-2 and c-Met Kinases

发现新型哌啶基苯并恶唑衍生物作为靶向VEGFR-2和c-Met激酶的抗癌药物

Eldehna, Wagdy M; Elsayed, Zainab M; Elnagar, Mohamed R; El-Said, Ahmed H; Majrashi, Taghreed A; Negmeldin, Ahmed T; Saleh, Abdulrahman M; Elrayess, Ranza; Elnahriry, Khaled A; Chen, Zhi-Long; Elagawany, Mohamed; Tawfik, Haytham O

Targeted synthesis of a trimethoxyphenyltetrahydropyrimidine analogue designed as a DNA intercalator: in silico, multi-spectroscopic, thermodynamic, and in vitro approaches

以DNA嵌入剂为设计目标的三甲氧基苯基四氢嘧啶类似物的靶向合成:计算机模拟、多光谱学、热力学和体外方法

Al-Karmalawy, Ahmed A; Elmaaty, Ayman Abo; Magdy, Galal; Radwan, Aya Saad; Alnajjar, Radwan; Shaldam, Moataz A; Al Khatib, Arwa Omar; Almujri, Salem Salman; Abdullah Alzahrani, Abdullah Yahya; Tawfik, Haytham O

Next-Generation Proteolysis-Targeting Chimeras in Precision Oncology: Multifunctional Designs, Emerging Modalities, and Translational Prospects in Targeted Protein Degradation

下一代蛋白水解靶向嵌合体在精准肿瘤学中的应用:多功能设计、新兴模式及靶向蛋白降解的转化前景

Nafie, Mohamed S; Diab, Mohamed K; Yassen, Asmaa S A; Elshamy, Amany M; El Tohamy, Mohamed R; Tawfik, Haytham O; Fahmy, Sherif Ashraf

Pharmacophore modeling: advances and pitfalls

药效团模型:进展与不足

Elsaka, Mahmoud Y; Taha, M Modather; Tayel, Amr; Tawfik, Haytham O; Ibrahim, Mahmoud A A; Shoeib, Tamer

Donepezil-based rational design of N-substituted quinazolinthioacetamide candidates as potential acetylcholine esterase inhibitors for the treatment of Alzheimer's disease: in vitro and in vivo studies

基于多奈哌齐的N-取代喹唑啉硫代乙酰胺类化合物的合理设计:作为治疗阿尔茨海默病的潜在乙酰胆碱酯酶抑制剂:体外和体内研究

Al-Karmalawy, Ahmed A; Mohamed, Ahmed F; Shalaby, Heba Nasr; Elmaaty, Ayman Abo; El-Shiekh, Riham A; Zeidan, Mohamed A; Alnajjar, Radwan; Alzahrani, Abdullah Yahya Abdullah; Al Mughram, Mohammed H; Shaldam, Moataz A; Tawfik, Haytham O